Ciprofloxacin-d8 (hydrochloride)

An internal standard for the quantification of ciprofloxacin

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
500ug

￥537.00

430.00

- +
1mg

￥850.00

680.00

- +
5mg

￥2912.00

2330.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

货号: ajci64680
CAS: 1216659-54-9
别名: 1-环丙基-6-氟-4-氧-7-哌嗪-D8-1-基-1,4-二氢-喹啉-3-羧酸盐酸盐水合物,Bay-09867-d8 hydrochloride
分子式: C17H10D8FN3O3 ? HCl
分子量: 375.9
纯度: >98%
溶解度: Methanol: Slightly Soluble,Water: Slightly Soluble
储存: Store at -20°C
库存: 现货

Background

Ciprofloxacin-d8 is intended for use as an internal standard for the quantification of ciprofloxacin by GC- or LC-MS. Ciprofloxacin is a fluoroquinolone antibiotic. It is active against a variety of Gram-positive and Gram-negative bacteria in vitro, including S. aureus, L. monocytogenes, P. aeruginosa, Legionella, N. gonorrhoeae, and H. pylori (MIC50s = 0.004-1 µg/ml). It is also active against clinical isolates of Bacteroides, Fusobacterium, Eubacterium, Actinomyces, Peptococcus, Peptostreptococcus, and Streptococcus in vitro (MIC50s = 0.5-2 µg/ml). Ciprofloxacin inhibits S. aureus DNA gyrase and topoisomerase IV (IC50s = 13.5 and 5.76 µg/ml, respectively). It reduces mortality in mouse models of intraperitoneal E. coli, P. vulgaris, K. pneumoniae, P. aeruginosa, and S. aureus infection (ED90-100s = 1-5, 2.5-5, 5-10, 20-40, and 80 mg/kg, respectively) and prevents mortality in a mouse model of subcutaneous S. typhimurium infection at 10 mg/kg. Formulations containing ciprofloxacin have been used in the treatment of bacterial infections.